MedTrace Logo

TARGET Study: Safety and Performance of the Cardiovalve TR Replacement System

NCT05486832 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 157

Last updated 2026-05-11

No results posted yet for this study

Summary

The objective of this study is to evaluate the safety and performance of Cardiovalve TR system

Conditions

  • Tricuspid Regurgitation

Interventions

DEVICE

Cardiovalve TR valve replacement System

The Cardiovalve system includes a valve and delivery system, designed for replacement of the tricuspid valve through a transcatheter.

Sponsors & Collaborators

  • Cardiovalve Ltd.

    lead INDUSTRY

Principal Investigators

  • Georg Nickenig, Dr · Bonn Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-09
Primary Completion
2026-03-15
Completion
2031-12-15

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05486832 on ClinicalTrials.gov